Role of epigenetics-microRNA axis in drug resistance of multiple myeloma
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Role of epigenetics-microRNA axis in drug resistance of multiple myeloma
Authors
Keywords
Epigenetics, EZH2, MicroRNA, Myeloma, Drug resistance
Journal
Journal of Hematology & Oncology
Volume 10, Issue 1, Pages -
Publisher
Springer Nature
Online
2017-06-17
DOI
10.1186/s13045-017-0492-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- RECQ1 helicase is involved in replication stress survival and drug resistance in multiple myeloma
- (2017) E Viziteu et al. LEUKEMIA
- Epigenetic strategies to reverse drug resistance in heterogeneous multiple myeloma
- (2017) Mark E. Issa et al. Clinical Epigenetics
- miR-137 Suppresses the Phosphorylation of AKT and Improves the Dexamethasone Sensitivity in Multiple Myeloma Cells Via Targeting MITF
- (2016) Benping Zhang et al. CURRENT CANCER DRUG TARGETS
- Epigenetic silencing of miR-137 induces drug resistance and chromosomal instability by targeting AURKA in multiple myeloma
- (2016) Y Qin et al. LEUKEMIA
- A novel hypoxia-selective epigenetic agent RRx-001 triggers apoptosis and overcomes drug resistance in multiple myeloma cells
- (2016) D Sharma Das et al. LEUKEMIA
- Therapeutic Targeting of miR-29b/HDAC4 Epigenetic Loop in Multiple Myeloma
- (2016) Nicola Amodio et al. MOLECULAR CANCER THERAPEUTICS
- Loss of the histone methyltransferase EZH2 induces resistance to multiple drugs in acute myeloid leukemia
- (2016) Stefanie Göllner et al. NATURE MEDICINE
- Targeting EZH2 in cancer
- (2016) Kimberly H Kim et al. NATURE MEDICINE
- MMSET/WHSC1 enhances DNA damage repair leading to an increase in resistance to chemotherapeutic agents
- (2016) M Y Shah et al. ONCOGENE
- Suppression of 19S proteasome subunits marks emergence of an altered cell state in diverse cancers
- (2016) Peter Tsvetkov et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- MicroRNA-21 induces 5-fluorouracil resistance in human pancreatic cancer cells by regulatingPTENandPDCD4
- (2016) Xueju Wei et al. Cancer Medicine
- Pathogenesis beyond the cancer clone(s) in multiple myeloma
- (2015) G. Bianchi et al. BLOOD
- Functional role of miR-10b in tamoxifen resistance of ER-positive breast cancer cells through down-regulation of HDAC4
- (2015) Aamir Ahmad et al. BMC CANCER
- Epigenetics and miRNA as predictive markers and targets for lung cancer chemotherapy
- (2015) Raafat A El-Awady et al. CANCER BIOLOGY & THERAPY
- Targeting the miR-221-222/PUMA/BAK/BAX Pathway Abrogates Dexamethasone Resistance in Multiple Myeloma
- (2015) J.-J. Zhao et al. CANCER RESEARCH
- A 13 mer LNA-i-miR-221 Inhibitor Restores Drug Sensitivity in Melphalan-Refractory Multiple Myeloma Cells
- (2015) A. Gulla et al. CLINICAL CANCER RESEARCH
- miR-137 and miR-197 Induce Apoptosis and Suppress Tumorigenicity by Targeting MCL-1 in Multiple Myeloma
- (2015) Y. Yang et al. CLINICAL CANCER RESEARCH
- Histone deacetylation meets miRNA: epigenetics and post-transcriptional regulation in cancer and chronic diseases
- (2015) Stefan Swierczynski et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Phosphorylation-mediated EZH2 inactivation promotes drug resistance in multiple myeloma
- (2015) Jiro Kikuchi et al. JOURNAL OF CLINICAL INVESTIGATION
- Molecular mechanisms in multiple myeloma drug resistance
- (2015) Nicholas Nikesitch et al. JOURNAL OF CLINICAL PATHOLOGY
- EZH2 Inhibition Blocks Multiple Myeloma Cell Growth through Upregulation of Epithelial Tumor Suppressor Genes
- (2015) H. Hernando et al. MOLECULAR CANCER THERAPEUTICS
- miR-335 Targets SIAH2 and Confers Sensitivity to Anti-Cancer Drugs by Increasing the Expression of HDAC3
- (2015) Youngmi Kim et al. MOLECULES AND CELLS
- Study on the Association Between miRNA-202 Expression and Drug Sensitivity in Multiple Myeloma Cells
- (2015) Xianjuan Shen et al. PATHOLOGY & ONCOLOGY RESEARCH
- Role of Histone Deacetylase Inhibitors in Relapsed Refractory Multiple Myeloma: A Focus on Vorinostat and Panobinostat
- (2015) Salma Afifi et al. PHARMACOTHERAPY
- Rational combination treatment with histone deacetylase inhibitors and immunomodulatory drugs in multiple myeloma
- (2015) T Hideshima et al. Blood Cancer Journal
- MicroRNA-451 regulates stemness of side population cells via PI3K/Akt/mTOR signaling pathway in multiple myeloma
- (2015) Juan Du et al. Oncotarget
- miR-29s: a family of epi-miRNAs with therapeutic implications in hematologic malignancies
- (2015) Nicola Amodio et al. Oncotarget
- In Vitro and in Vivo Anti-tumor Activity of miR-221/222 Inhibitors in Multiple Myeloma
- (2015) Maria Teresa Di Martino et al. Oncotarget
- Shear enhances thrombopoiesis and formation of microparticles that induce megakaryocytic differentiation of stem cells
- (2014) J. Jiang et al. BLOOD
- miR-30-5p Functions as a Tumor Suppressor and Novel Therapeutic Tool by Targeting the Oncogenic Wnt/β-Catenin/BCL9 Pathway
- (2014) Jian-Jun Zhao et al. CANCER RESEARCH
- Dysregulated Class I histone deacetylases are indicators of poor prognosis in multiple myeloma
- (2014) Sridurga Mithraprabhu et al. Epigenetics
- MiR-29b replacement inhibits proteasomes and disrupts aggresome+autophagosome formation to enhance the antimyeloma benefit of bortezomib
- (2014) S Jagannathan et al. LEUKEMIA
- Global Epigenetic Regulation of MicroRNAs in Multiple Myeloma
- (2014) Wenjing Zhang et al. PLoS One
- Overcoming inherent resistance to histone deacetylase inhibitors in multiple myeloma cells by targeting pathways integral to the actin cytoskeleton
- (2014) S Mithraprabhu et al. Cell Death & Disease
- Polycomb protein EZH2 suppresses apoptosis by silencing the proapoptotic miR-31
- (2014) Q Zhang et al. Cell Death & Disease
- Pharmaco-miR: linking microRNAs and drug effects
- (2013) J. L. Rukov et al. BRIEFINGS IN BIOINFORMATICS
- Improved risk stratification in myeloma using a microRNA-based classifier
- (2013) Ping Wu et al. BRITISH JOURNAL OF HAEMATOLOGY
- Attenuation of dexamethasone-induced cell death in multiple myeloma is mediated by miR-125b expression
- (2013) Megan Murray et al. CELL CYCLE
- Targeting miR-21 Inhibits In Vitro and In Vivo Multiple Myeloma Cell Growth
- (2013) E. Leone et al. CLINICAL CANCER RESEARCH
- Histone Deacetylase Inhibitors in Multiple Myeloma: Rationale and Evidence for Their Use in Combination Therapy
- (2013) Jonathan L. Kaufman et al. Clinical Lymphoma Myeloma & Leukemia
- Aberrant microRNA expression in multiple myeloma
- (2013) Konstantinos Dimopoulos et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Restoration of microRNA-214 expression reduces growth of myeloma cells through positive regulation of P53 and inhibition of DNA replication
- (2013) I. Misiewicz-Krzeminska et al. HAEMATOLOGICA
- Disruption of the MYC-miRNA-EZH2 loop to suppress aggressive B-cell lymphoma survival and clonogenicity
- (2013) X Zhao et al. LEUKEMIA
- MicroRNA theragnostics for the clinical management of multiple myeloma
- (2013) N Ahmad et al. LEUKEMIA
- Synergistic Induction of Apoptosis in Multiple Myeloma Cells by Bortezomib and Hypoxia-Activated Prodrug TH-302, In Vivo and In Vitro
- (2013) J. Hu et al. MOLECULAR CANCER THERAPEUTICS
- DNA methylation of microRNA genes in multiple myeloma
- (2012) K. Y. Wong et al. CARCINOGENESIS
- Promises and Challenges of MicroRNA-based Treatment of Multiple Myeloma
- (2012) P. Tagliaferri et al. CURRENT CANCER DRUG TARGETS
- MicroRNA-21 regulates the sensitivity of diffuse large B-cell lymphoma cells to the CHOP chemotherapy regimen
- (2012) Haitao Bai et al. INTERNATIONAL JOURNAL OF HEMATOLOGY
- MMSET stimulates myeloma cell growth through microRNA-mediated modulation of c-MYC
- (2012) D-J Min et al. LEUKEMIA
- Circulating microRNA expression is associated with genetic subtype and survival of multiple myeloma
- (2012) Jing-jing Huang et al. MEDICAL ONCOLOGY
- Latest advances and current challenges in the treatment of multiple myeloma
- (2012) Anuj Mahindra et al. Nature Reviews Clinical Oncology
- Epigenetic stability, adaptability, and reversibility in human embryonic stem cells
- (2012) J. D. Tompkins et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Bortezomib action in multiple myeloma: microRNA-mediated synergy (and miR-27a/CDK5 driven sensitivity)?
- (2012) E Ballabio et al. Blood Cancer Journal
- Overexpression of microRNA-29b induces apoptosis of multiple myeloma cells through down regulating Mcl-1
- (2011) Yi-Kun Zhang et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Up-regulation ofmiR-21Mediates Resistance to Trastuzumab Therapy for Breast Cancer
- (2011) Chang Gong et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Suppressing miRNA-15a/-16 expression by interleukin-6 enhances drug-resistance in myeloma cells
- (2011) Mu Hao et al. Journal of Hematology & Oncology
- Myeloma cell adhesion to bone marrow stromal cells confers drug resistance by microRNA-21 up-regulation
- (2011) Xudong Wang et al. LEUKEMIA & LYMPHOMA
- Mechanism of Action of Proteasome Inhibitors and Deacetylase Inhibitors and the Biological Basis of Synergy in Multiple Myeloma
- (2011) T. Hideshima et al. MOLECULAR CANCER THERAPEUTICS
- Initial genome sequencing and analysis of multiple myeloma
- (2011) Michael A. Chapman et al. NATURE
- Epigenetic Inactivation of the miR-124-1 in Haematological Malignancies
- (2011) Kwan Yeung Wong et al. PLoS One
- Interplay between microRNAs and the epigenetic machinery: An intricate network
- (2010) Marilena V. Iorio et al. Biochimica et Biophysica Acta-Gene Regulatory Mechanisms
- Histone deacetylases are critical targets of bortezomib-induced cytotoxicity in multiple myeloma
- (2010) J. Kikuchi et al. BLOOD
- Aberrant global methylation patterns affect the molecular pathogenesis and prognosis of multiple myeloma
- (2010) B. A. Walker et al. BLOOD
- Downregulation of p53-inducible microRNAs 192, 194, and 215 Impairs the p53/MDM2 Autoregulatory Loop in Multiple Myeloma Development
- (2010) Flavia Pichiorri et al. CANCER CELL
- Down-regulated miR-331-5p and miR-27a are associated with chemotherapy resistance and relapse in leukaemia
- (2010) Dan-Dan Feng et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Deregulation of microRNA expression in the different genetic subtypes of multiple myeloma and correlation with gene expression profiling
- (2010) N C Gutiérrez et al. LEUKEMIA
- Polycomb Target Genes Are Silenced in Multiple Myeloma
- (2010) Antonia Kalushkova et al. PLoS One
- DNA methylation alterations in multiple myeloma as a model for epigenetic changes in cancer
- (2010) Amy Sharma et al. Wiley Interdisciplinary Reviews-Systems Biology and Medicine
- Identification of microRNA expression patterns and definition of a microRNA/mRNA regulatory network in distinct molecular groups of multiple myeloma
- (2009) M. Lionetti et al. BLOOD
- MicroRNAs 15a and 16 regulate tumor proliferation in multiple myeloma
- (2009) A. M. Roccaro et al. BLOOD
- Genomic Screening for Genes Silenced by DNA Methylation Revealed an Association between RASD1 Inactivation and Dexamethasone Resistance in Multiple Myeloma
- (2009) M. Nojima et al. CLINICAL CANCER RESEARCH
- Phase I trial of oral vorinostat (suberoylanilide hydroxamic acid, SAHA) in patients with advanced multiple myeloma
- (2008) Paul Richardson et al. LEUKEMIA & LYMPHOMA
- Roles of the EZH2 histone methyltransferase in cancer epigenetics
- (2008) Jeffrey A. Simon et al. MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS
- MicroRNAs regulate critical genes associated with multiple myeloma pathogenesis
- (2008) F. Pichiorri et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now